Trial
NCT05223647
Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer
Phase IIITERMINATEDSAFETYConfidence: HIGH
Sponsor
Norwegian University of Science and Technology
Collaborators
St. Olavs Hospital; Haukeland University Hospital; University Hospital of North Norway; Alesund Hospital; Helse Stavanger HF; Oslo University Hospital; Helse Nord-Trøndelag HF; Helse Fonna; Drammen sykehus; University Hospital, Akershus; Erasmus Medical Center; Sahlgrenska University Hospital; Karolinska University Hospital; Gävle Hospital; Sykehuset Innlandet HF; North Estonia Medical Centre; Nordlandssykehuset HF; Landspitali University Hospital; Lund University Hospital; University Hospital, Linkoeping
Condition
Small-cell Lung Cancer
Intervention
Thoracic radiotherapy
Why stopped
Termination was adviced by Data Safety Committee due to excess toxicity of the experimental treatment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-28